These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15858011)

  • 1. Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment.
    Gros L; Dreja H; Fiser AL; Plays M; Pelegrin M; Piechaczyk M
    J Virol; 2005 May; 79(10):6272-80. PubMed ID: 15858011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy.
    Gros L; Pelegrin M; Plays M; Piechaczyk M
    J Virol; 2006 Oct; 80(20):10191-200. PubMed ID: 17005696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice.
    Gros L; Pelegrin M; Michaud HA; Bianco S; Hernandez J; Jacquet C; Piechaczyk M
    J Virol; 2008 Feb; 82(3):1339-49. PubMed ID: 18032505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.
    Michaud HA; Gomard T; Gros L; Thiolon K; Nasser R; Jacquet C; Hernandez J; Piechaczyk M; Pelegrin M
    PLoS Pathog; 2010 Jun; 6(6):e1000948. PubMed ID: 20548955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
    Nasser R; Pelegrin M; Michaud HA; Plays M; Piechaczyk M; Gros L
    J Virol; 2010 Oct; 84(19):10169-81. PubMed ID: 20610721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother-to-baby transfer of humoral immunity against retrovirus-induced neurologic disorders and immunodeficiency.
    Saha K; Hollowell D; Wong PK
    Virology; 1994 Jan; 198(1):129-37. PubMed ID: 8259648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.
    Nasser R; Pelegrin M; Plays M; Gros L; Piechaczyk M
    Blood; 2013 Feb; 121(7):1102-11. PubMed ID: 23264590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated protection against respiratory viral infection.
    Dubois ME; Yoshihara P; Slifka MK
    Semin Respir Crit Care Med; 2005 Dec; 26(6):635-42. PubMed ID: 16388432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How the bovine viral diarrhea virus outwits the immune system].
    Peterhans E; Jungi TW; Schweizer M
    Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):124-9. PubMed ID: 16716045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
    Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
    Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III.
    Phillpotts RJ
    Virus Res; 2006 Sep; 120(1-2):107-12. PubMed ID: 16621103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.
    Trkola A; Kuster H; Rusert P; Joos B; Fischer M; Leemann C; Manrique A; Huber M; Rehr M; Oxenius A; Weber R; Stiegler G; Vcelar B; Katinger H; Aceto L; Günthard HF
    Nat Med; 2005 Jun; 11(6):615-22. PubMed ID: 15880120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral infection].
    Tsutsumi H
    Nihon Rinsho; 2002 Mar; 60(3):585-90. PubMed ID: 11904977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
    Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
    Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.